Three variants in RBM12, one variant in NDUFB6, ten variants in DLGAP4-AS1, five variants in ATPV1A, eleven variants in RECK, four variants in SLC35E1, eight variants in RFX3, and eight variants in ATP8A1 were known somatically acquired mutations in various cancers. This evidence concerns the gene ATP8A1 and cancer.